Consensus Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Real-time Estimate Cboe BZX Other stock markets 01:55:50 2024-04-25 pm EDT			5-day change	1st Jan Change
135.3 ^USD	-1.67%		+7.26%	-2.05%

12:59pm	Labcorp beats quarterly estimates on strong testing demand	RE
Apr. 24	Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	MT

Evolution of the average Target Price on Quest Diagnostics Incorporated

Price target over the last 5 years

History of analyst recommendation changes

2c905483c23b2ae556f19919256.GiLcTt__-yGM09PoSumg_fWhofxad_icAfmT4M67h9g.eWeyJr2Py2n_tpCiIrPLtZrKzY9uAZn6ZrLfqaOO8axAdrcP56akY7y9sA~faa8b575ae694925a6c32f7d22096e93

Analyst Recommendations on Quest Diagnostics Incorporated

Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	Apr. 24	MT
UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating	Apr. 24	MT
Barclays Raises Quest Diagnostics' Price Target to $144 From $138	Apr. 24	MT
Deutsche Bank Adjusts Quest Diagnostics Price Target to $136 From $125, Maintains Hold Rating	Apr. 24	MT
Mizuho Adjusts Quest Diagnostics' Price Target to $155 From $150	Apr. 24	MT
Citigroup Adjusts Quest Diagnostics Price Target to $145 From $135	Apr. 24	MT
Leerink Partners Adjusts Quest Diagnostics Price Target to $141 From $135	Apr. 24	MT
Truist Raises Price Target on Quest Diagnostics to $150 From $145, Cites 'Strong Start' to 2024, Keeps Hold Rating	Apr. 24	MT
Evercore ISI Raises Quest Diagnostics Price Target to $145 from $140	Apr. 23	MT
Leerink Partners Starts Quest Diagnostics With Market Perform Rating, $135 Price Target	Feb. 26	MT
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	Feb. 21
Jefferies Upgrades Quest Diagnostics to Buy From Hold, Adjusts Price Target to $155 From $140	Feb. 07	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	Feb. 07
Deutsche Bank Adjusts Quest Diagnostics Price Target to $125 From $140, Maintains Hold Rating	Feb. 02	MT
ANALYST RECOMMENDATIONS : Burberry Group, Blackrock, JPMorgan Chase, Qualcomm, Sage...	Jan. 15
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
Truist Raises Quest Diagnostics' Price Target to $150 From $145, Keeps Hold Rating	Dec. 20	MT
BofA Securities Upgrades Quest Diagnostics to Buy From Neutral, Adjusts Price Target to $160 From $140	Dec. 12	MT
Citigroup Adjusts Price Target on Quest Diagnostics to $145 From $130, Keeps Neutral Rating	Dec. 11	MT
ANALYST RECOMMENDATIONS : Adobe, AMD, Apple, Costco, HP, Snap...	Dec. 11
UBS Adjusts Quest Diagnostics Price Target to $137 From $135, Maintains Neutral Rating	Dec. 07	MT
JPMorgan Chase Adjusts Price Target on Quest Diagnostics to $149 From $148, Maintains Neutral Rating	Nov. 17	MT
Investors see life through rose-colored glasses	Nov. 17
ANALYST RECOMMENDATIONS : Air Products & Chemicals, Barclays, Glencore, Mastercard, Walmart...	Nov. 17

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

137.6 USD

Average target price

146 USD

Spread / Average Target

+6.17%

High Price Target

160 USD

Spread / Highest target

+16.32%

Low Price Target

136 USD

Spread / Lowest Target

-1.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Quest Diagnostics Incorporated

Jefferies & Co.
UBS
Barclays
Deutsche Bank Securities
Mizuho Securities
Citigroup
Leerink Partners
Truist Securities
Evercore ISI
BofA Securities
JPMorgan Chase
Piper Sandler
Morgan Stanley
Baptista Research
Wells Fargo Securities
Credit Suisse
Baird
KeyBanc Capital Markets

Ratings for Quest Diagnostics Incorporated

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar